Singapore's Covid-19 neutralising antibody test kit first to get US FDA approval; eight cases on Mon (Nov 9)

cPass does not require highly specialised equipment or training to use, and returns results in just an hour. - The Straits Times/Asian News Network

SINGAPORE, Nov 9 (The Straits Times/ANN): A kit that detects whether someone has antibodies which neutralise the coronavirus, invented by local researchers, has become the first of its kind to receive authorisation from the United States' Food and Drug Administration (FDA).

On Friday (Nov 6), the FDA said on its website that it had given emergency use authorisation for the kit, known as cPass.